REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Biofarmacija (Lithuania)

Main Activities: General Line Grocery Merchant Wholesalers | All Other Ambulatory Health Care Services
Secondary Activities: Other Food Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers | Fish and Seafood Merchant Wholesalers
Full name: UAB Biofarmacija Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Biofarmacija is based in Lithuania. The head office is in Klaipeda. It operates in the General Line Grocery Merchant Wholesalers industry. The enterprise was incorporated on December 21, 2011. There are currently 16 (2025) people employed by UAB Biofarmacija. From the latest financial highlights, UAB Biofarmacija reported a net sales revenue increase of 19.03% in 2024. The net profit margin of UAB Biofarmacija decreased by 0.02% in 2024.

Headquarters
Taikos pr. 9-54
Klaipeda; Klaipeda County; Postal Code: LT-91134

Contact Details: Purchase the UAB Biofarmacija report to view the information.

Basic Information
Total Employees:
Purchase the UAB Biofarmacija report to view the information.
Registered Capital:
Purchase the UAB Biofarmacija report to view the information.
Financial Auditors:
Purchase the UAB Biofarmacija report to view the information.
Incorporation Date:
December 21, 2011
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Biofarmacija report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
19.03%
Total operating revenue
19.03%
Net Profit (Loss) for the Period
18.79%
Total equity
18.17%
Net Profit Margin
-0.02%
Return on Equity (ROE)
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?